' fill='%23ffffff'%3E%3Cpath d='M283.94,167.31l386.39,516.64L281.5,1104h87.51l340.42-367.76L984.48,1104h297.8L874.15,558.3l361.92-390.99 h-87.51l-313.51,338.7l-253.31-338.7H283.94z M412.63,231.77h136.81l604.13,807.76h-136.81L412.63,231.77z'%3E%3C/path%3E%3C/g%3E%3C/svg%3E%0A){kind=small}
Search result
CSO guidance on clinical research in response to additional lockdown measures
Research, development and innovation are crucial in the response to the COVID-19 pandemic and are a core component of NHS Scotland’s role as a person-centred, evidence-based healthcare system. On January 4th, additional lockdown measures were put in place by the Scottish Government to safeguard health, save lives and protect the NHS in the context of a steep rise in Coronavir...
CSO Festive Message 2020
Euan Dick, Head of the Chief Scientist Office (CSO) reflects on 2020 as one of the most challenging and transformative years for research, paying tribute to the incredible commitment, resilience and talent of the research community across Scotland. “Last year, just three months into my post as Head of the Chief Scientist Office I used my festive message to highlight the critical imp...
Vacancy: NRS Cardiovascular Clinical Lead
The Chief Scientist Office is looking to appoint a clinical lead for NRS Cardiovascular Hours: 0.2FTE/ 2PAs per weekSalary: pro-rata within the post holder’s pay scaleLength: three years in the first instance, with the possibility to extend The remit of th...
UK wide COVID-19 study recruits the first global patient in Dundee
A phase 3 trial for the COVID-19 vaccine developed by The Janssen Pharmaceutical Companies of Johnson & Johnson has this week recruited the first global patient in Dundee. This latest study, co-funded by the UK government’s Vaccine Taskforce, and being delivered across the UK will recruit 30,000 people worldwide. It will test the safety and effectiveness of a new vaccine with two doses called ENSEMBLE 2. James Brook, Head of Clinical...
Novavax Phase 3 COVID-19 vaccine trial completes enrollment in two months
The Novavax Phase 3 COVID-19 vaccine trial has achieved its recruitment target just two months after opening in the UK - with 15,203 volunteers from across the country recruited in record time, including participants from the North East of Scotland. The Novavax study is now the largest double blind, placebo-controlled COVID-19 vaccine trial to be undertaken in the UK so far. The pivotal...
Genes could be key to new COVID-19 treatments
Potential treatments for COVID-19 have been identified after the discovery of five genes associated with the most severe form of the disease. The research led by University of Edinburgh has now been published in Nature (11 December 2020). Genetic evidence is second only to clinical trials as a way to tell which treatments will be effecti...
Vacancy: NRS Clinical Leads
The Chief Scientist Office of the Scottish Government (CSO) is seeking applicants for the role of Clinical Leads within NRS Neuroprogressive and Dementia (NRS NDN) and NRS Primary Care Hours: 0.2FTE/ 2PAs per weekSalary: Pro-rata within the post holder’s pay scaleLength : 3 years in the first instance, with the possibility to ex...
Major COVID-19 vaccine trial opens in Scotland
Hundreds of people from across Tayside and Fife are being sought to participate in a Covid-19 vaccine trial to be led by the University of Dundee and NHS Tayside. From Monday (16 November), the University and health board will initiate the second Phase 3 clinical trial of a vaccine candidate developed by Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. Researchers are seeking 400 members of the public to volunteer for the study, which will see participants receive t...
Join the SPaRc/NRS Steering Committee
An opportunity for an Early Career Researcher or trainee healthcare professional to join the SPaRC/ NRS Pain Steering committee. The committee encompasses a multidisciplinary membership, representing a wide range of expertise. The remit is to promote the aspirations that: Clinical practice in managing chronic pain is informed by current research, and; Current research in chronic pain is relevant to c...
Update on health and social care research projects for educational purposes
A pause on health and social care research projects for educational purposes has been extended until September 2021 The decision is in line with national priorities for NHS/Health and Social Care to support COVID-19 studies and the restart of clinical trials and studies as well the continuing pressure of the COVID-19 pandemic. This decision has been taken by the Health Research Authority (HRA) in collaboration with partners in the...
